The Latest Cardiac and Vascular News
CARLSBAD, Calif., May 12, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter of 2022 and announced a leadership transition. Recent Updates: Reported revenue […]
— Company to host call at 9:00am today with CEO, CFO, CMO and VP Sales & Marketing — NEWTOWN, Pa., May 12, 2022 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended […]
Biofourmis Care, a comprehensive care management platform including virtual multidisciplinary care teams, to be evaluated against in-person care among underserved patients with chronic cardiovascular conditions BOSTON, May 12, 2022 /PRNewswire/ — Biofourmis, a Boston-based global leader in virtual care and digital medicine, announced today that its Biofourmis Care solution has been selected by the American […]
– RAPID topline data readout remains on track for mid-second half 2022 – Results from NODE-302 study highlights etripamil safety and reduced need for ED interventions MONTREAL and CHARLOTTE, N.C., May 12, 2022 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results […]
HOUSTON, May 12, 2022 /PRNewswire/ — Tim Daugherty, CEO of Millar, Inc., a medical device manufacturer and OEM pressure-sensor solutions provider, is honored to be named one of The Top 50 Healthcare Technology CEOs of 2022, published by the Healthcare Technology Report. Now more than ever, the importance of the healthcare technology field is […]
Financing To Support Commercial Acceleration of the Optimizer Smart Mini, Enrollment in the Landmark AIM HIGHer Clinical Trial, and Continued Development of a CCM-D Combination MARLTON, N.J., May 12, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure […]
SUNNYVALE, Calif., May 11, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the first quarter of 2022 and filed its quarterly report on Form 10-Q for the three months ended March 31, […]
– Secured access to new capital through debt and equity transactions – Increased utilization of Treprostinil Injection with increasing payer generic mandates – Advanced Hatch-Waxman litigation in support of final regulatory approval of YUTREPIA™ (treprostinil) inhalation powder – Company to host webcast and conference call today at 8:30 a.m. ET […]
LianBio’s partner, Bristol Myers Squibb, has received U.S. FDA approval of mavacamten for the treatment of patients with obstructive hypertrophic cardiomyopathy (oHCM) Registrational Phase 3 EXPLORER-CN clinical trial of mavacamten in Chinese patients with symptomatic oHCM ongoing LianBio’s partner, Tarsus, announced positive topline data from the Phase 3 Saturn-2 clinical trial […]
TN-201 Received Orphan Medicinal Product Designation from the European Commission Preclinical TN-401 Data Presented at Heart Rhythm 2022 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today […]
